ArticleJournal of neuro-oncology2026
Small and medium/large glioblastoma extracellular vesicles differentially regulate endothelial and mitochondrial function in blood-brain barrier and peripheral vasculature models.
Article in Journal of neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeExtracellular vesicles (EVs) released by glioblastoma (GBM) cells circulate systemically and modulate tumour-host interactions, influencing vascular function both within and beyond the tumour microenvironment. The EVs span a size range from tens to hundreds of nanometres; however, the specific effects of distinct GBM-derived EV size subpopulations on endothelial function across different endothelial cell types remain poorly understood.
methodsIn this study, we investigated the effects of enriched small EVs (sEV) and medium/large EVs (m/lEV) fractions derived from human GBM cell line HROG36 on endothelial barrier integrity (assessed by transendothelial electrical resistance (TEER) and tight junction (TJ) protein analysis), migration (wound healing assay), angiogenic capacity (tube formation on extracellular matrix), and mitochondrial function (assessed by measuring the oxygen consumption rate (OCR)) in human brain microvascular endothelial cells (hCMEC/D3), representing blood–brain barrier (BBB) model, and peripheral endothelial cells (HUVECs).
resultsWe show that sEV-enriched fractions significantly impaired endothelial barrier integrity in both cell types, as evidenced by reduced TEER and disrupted TJ protein organisation. In contrast, m/lEV-enriched fractions enhanced endothelial cell migration while suppressing angiogenic network formation, resulting in disorganised, shortened capillary-like structures. These pro-migratory and anti-angiogenic effects of m/lEVs were accompanied by a selective suppression of mitochondrial respiration in hCMEC/D3 cells, with no such effect observed in HUVECs, indicating that the functional alterations are linked to altered bioenergetic activity specifically in BBB endothelial cells.
conclusionOur data indicate that sEV and m/lEV-enriched subpopulations derived from GBM exert distinct vascular effects, underscoring their potential as functionally distinct EV-based biomarkers and informing the development of personalised therapeutic strategies in GBM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.